Generics Industry Hungry For More After Showing Larger GLP-1 Appetite In 2024
Sandoz, Viatris Look To Be In Commercial Vanguard; Supply Core, CDMOs Vital
GLP-1 drugs like Ozempic and Mounjaro have shaken up pharma, crossing firmly over into the mainstream while netting fortunate suppliers billions of dollars in the process. As patent expiry approaches for first- and second-generation products, generics manufacturers are gearing up to take a share of the spoils.
